Items where SHU Author is "Miller, Keith"

Up a level
Export as [feed] RSS
Group by: Item Type | Full Text | No Grouping
Number of items: 13.

HARRISON, Patrick L, ABDEL-RAHMAN, Mohamed, MILLER, Keith and STRONG, Peter (2014). Antimicrobial peptides from scorpion venoms. Toxicon, 88, 115-137.

KHAN, Akram, MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and Antimicrobial Activity of Novel Substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240.

KHAN, M., MILLER, Keith, RAINSFORD, Kim and ZHOU, Yong (2013). Synthesis and antimicrobial activity of novel substituted Ethyl 2-(Quinolin-4-yl)-propanoates. Molecules, 18 (3), 3227-3240.

MILLER, K., DUNSMORE, C. J., LEEDS, J. A., PATCHING, S. G., SACHDEVA, M., BLAKE, K. L., STUBBINGS, W. J., SIMMONS, K. J., HENDERSON, P. J. F., DE LOS ANGELES, J., FISHWICK, C. W. G. and CHOPRA, I. (2010). Benzothioxalone derivatives as novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferases (MurA and MurZ). Journal of Antimicrobial Chemotherapy, 65 (12), 2566-2573.

MARINER, K R, TROWBRIDGE, R, AGARWAL, A K, MILLER, Keith, O'NEILL, A J, FISHWICK, C W and CHOPRA, I (2010). Furanyl-rhodanines are unattractive drug candidates for development as inhibitors of bacterial RNA polymerase. Antimicrobial Agents and Chemotherapy, 54 (10), 4506-4509.

OOI, N, MILLER, Keith, RANDALL, C, RHYS-WILLIAMS, W, LOVE, W and CHOPRA, I (2010). XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms. Journal of Antimicrobial Chemotherapy, 65 (1), 72-78.

OOI, N., MILLER, K., HOBBS, J., RHYS-WILLIAMS, W., LOVE, W. and CHOPRA, I. (2009). XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity. Journal of Antimicrobial Chemotherapy, 64 (4), 735-740.

DUNSMORE, C. J., MILLER, K., BLAKE, K. L., PATCHING, S. G., HENDERSON, P. J. F., GARNETT, J. A., STUBBINGS, W. J., PHILLIPS, S. E. V., PALESTRANT, D. J. and ANGELES, J. de L. (2008). 2-Aminotetralones: Novel inhibitors of MurA and MurZ. Bioorganic & Medicinal Chemistry Letters, 18 (5), 1730-1734.

HOBBS, J K, MILLER, Keith, O'NEILL, A J and CHOPRA, I (2008). Consequences of daptomycin-mediated membrane damage in Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 62 (5), 1003-1008.

MILLER, K., O'NEILL, A. J., WILCOX, M. H., INGHAM, E. and CHOPRA, I. (2008). Delayed Development of Linezolid Resistance in Staphylococcus aureus following Exposure to Low Levels of Antimicrobial Agents. Antimicrobial Agents and Chemotherapy, 52 (6), 1940-1944.

DRIFFIELD, K, MILLER, Keith, BOSTOCK, J M, O'NEILL, A J and CHOPRA, I (2008). Increased mutability of Pseudomonas aeruginosa in biofilms. Journal of Antimicrobial Chemotherapy, 61 (5), 1053-1056.

MILLER, K., DUNSMORE, C. J., FISHWICK, C. W. G. and CHOPRA, I. (2008). Linezolid and Tiamulin Cross-Resistance in Staphylococcus aureus Mediated by Point Mutations in the Peptidyl Transferase Center. Antimicrobial Agents and Chemotherapy, 52 (5), 1737-1742.

CHOPRA, I, SCHOFIELD, C, EVERETT, M, ONEILL, A, MILLER, Keith, WILCOX, M, FRERE, J, DAWSON, M, CZAPLEWSKI, L, URLEB, U and COURVALIN, P (2008). Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement. The Lancet Infectious Diseases, 8 (2), 133-139.

This list was generated on Wed Sep 3 00:40:57 2014 IST.